261 related articles for article (PubMed ID: 15650239)
1. Angiogenesis in neuroblastoma.
Ribatti D; Marimpietri D; Pastorino F; Brignole C; Nico B; Vacca A; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():133-42. PubMed ID: 15650239
[TBL] [Abstract][Full Text] [Related]
2. Schwann cell-conditioned medium inhibits angiogenesis.
Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
Cancer Res; 2000 Nov; 60(21):5966-71. PubMed ID: 11085514
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
[TBL] [Abstract][Full Text] [Related]
4. [Angiogenesis and tumor progression in melanoma].
Vacca A; Ria R; Ribatti D; Bruno M; Dammacco F
Recenti Prog Med; 2000 Nov; 91(11):581-7. PubMed ID: 11125952
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and anti-angiogenesis in neuroblastoma.
Ribatti D; Vacca A; Nico B; De Falco G; Giuseppe Montaldo P; Ponzoni M
Eur J Cancer; 2002 Apr; 38(6):750-7. PubMed ID: 11937307
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
7. [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects].
Vacca A; Ribatti D; Pellegrino A; Dammacco F
Ann Ital Med Int; 2000; 15(1):7-19. PubMed ID: 10842887
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice.
Spurbeck WW; Ng CY; Vanin EF; Davidoff AM
Cancer Gene Ther; 2003 Mar; 10(3):161-7. PubMed ID: 12637936
[TBL] [Abstract][Full Text] [Related]
9. Prospects for therapeutic inhibition of neuroblastoma angiogenesis.
Shusterman S; Maris JM
Cancer Lett; 2005 Oct; 228(1-2):171-9. PubMed ID: 15927358
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
11. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.
Jodele S; Chantrain CF; Blavier L; Lutzko C; Crooks GM; Shimada H; Coussens LM; Declerck YA
Cancer Res; 2005 Apr; 65(8):3200-8. PubMed ID: 15833851
[TBL] [Abstract][Full Text] [Related]
12. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
[TBL] [Abstract][Full Text] [Related]
13. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro.
Berthod F; Germain L; Tremblay N; Auger FA
J Cell Physiol; 2006 May; 207(2):491-8. PubMed ID: 16453301
[TBL] [Abstract][Full Text] [Related]
15. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
16. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
18. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
19. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]